Journal Mobile Options
Table of Contents
Vol. 79, No. 2, 2013
Issue release date: March 2013
Horm Res Paediatr 2013;79:114-118

Deep Vein Thrombosis and Pulmonary Embolism in a Child with Diabetic Ketoacidosis and Protein S Deficiency: A Case Report

Sdogou T. · Kossiva L. · Kakleas K. · Platokouki H. · Tentolouri T. · Georgouli H. · Karayianni C. · Karavanaki K.
a2nd Department of Pediatrics, ‘P&A Kyriakou' Children's Hospital, Athens University, and bHemophilia Centre and Hemostasis Unit, ‘Aghia Sophia' Children's Hospital, Athens, Greece

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Introduction: Diabetic ketoacidosis (DKA) is considered a hypercoagulable state, which may be exacerbated in patients with thrombophilia and lead to thrombosis. Case Report: We report on a 5.5-year-old boy, who was admitted to the pediatric department with DKA due to newly diagnosed type 1 diabetes. Low-grade fever was reported for 6 days prior to admission and continued during DKA management, with negative septic screening. After DKA management, the child developed symptoms of iliofemoral deep vein thrombosis (DVT). A family history of protein S (PS) deficiency was revealed. He was initially treated intravenously with antibiotics and unfractionated heparin, which, after 2 days, was switched to low-molecular-weight heparin and vitamin K antagonist (VKA) due to poor anticoagulant response. On the 6th day of anticoagulant treatment, the patient presented with pulmonary embolism (PE); he continued with VKA and antibiotics, with significant clinical improvement. Prolonged fever was attributed to DVT and PE. The patient was discharged on oral anticoagulants and insulin. Conclusion: We report on a child with congenital PS deficiency and DKA who developed DVT and PE despite anticoagulant treatment. It is important in children presenting with DKA to seek thoroughly for a medical history of thrombophilia and to start early thromboprophylaxis in such cases in order to prevent a possible thrombosis.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB: Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol 2003;108:175-181.
  2. Hoffman WH, Locksmith JP, Burton EM, Hobbs E, Passmore GG, Pearson-Shaver AL, Deane DA, Beaudreau M, Bassali RW: Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications 1998;12:314-320.
  3. Ho J, Mah JK, Hill MD, Pacaud D: Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of literature. Pediatr Diabetes 2006;7:116-121.
  4. Rosenbloom AL: Fatal cerebral infarctions in diabetic ketoacidosis in a child with previously unknown heterozygosity for factor V Leiden deficiency. J Pediatr 2004;145:561-562.
  5. Lee HS, Hwang JS: Cerebral infarction associated with transient visual loss in child with diabetic ketoacidosis. Diabet Med 2011;28:516-518.
  6. Worly JM, Fontenberry JD, Hansen I, Chambliss CR, Stockwell J: Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics 2004;113:e57.

    External Resources

  7. Quigley RL, Curran RD, Stagl RD, Alexander JC Jr: Management of massive pulmonary thromboembolism complicating diabetic ketoacidosis. Ann Thorac Surg 1994;57:1322-1324.
  8. Bonfanti R, Bognetti E, Meschi F, Medaglini S, D'Angelo A, Chiumello G: Disseminated intravascular coagulation and severe peripheral neuropathy complicating ketoacidosis in a newly diagnosed diabetic child. Acta Diabetol 1994;31:173-174.
  9. Carl GF, Hoffman WH, Passmore GG, Truemper EJ, Lightsey AL, Cornwell PE, Jonah MH: Diabetic ketoacidosis promotes a prothrombotic state. Endocr Res 2003;29:73-82.
  10. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 2000;130:963-974.
  11. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, Lalli C, Ciabattoni G, Davì G, Bolli GB: Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003;41:1013-1020.
  12. Vazzana N, Ranalli P, Cuccurullo C, Davì G: Diabetes mellitus and thrombosis. Thromb Res 2012;129:371-317.
  13. Vambergue A, Rugeri L, Gaveriaux V, Devos P, Martin A, Fermon C, Fontaine P, Jude B: Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. Thromb Res 2001;101:367-375.
  14. Bilici M, Tavil B, Dogru O, Davutoglu M, Bosnak M: Diabetic ketoasidosis is associated with prothrombotic tendency in children. Pediatr Hematol Oncol 2011;28:418-424.
  15. Bauer KA: Protein S deficiency. 2008.
  16. Vukovich T, Schernthaner G: Decreased protein C levels in patients with insulin-dependent diabetes mellitus. Diabetes 1986;35:617-619.

    External Resources

  17. Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WRW, Rosenbloom A, Sperling MA, Hanas R: ISPAD Clinical Practice Consensus Guidelines 2006-2007: diabetic ketoacidosis. Pediatric Diabetes 2007;8:28-42.
  18. Marnejon T, Angelo D, Abu Abdou A, Gemmel D: Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J Vasc Access 2012;13:231-238.

    External Resources

  19. Kazmers A, Groehn H, Meeker C: Do patients with acute deep vein thrombosis have fever? Am Surg 2000;66:598-601.

    External Resources

  20. Murray HW, Ellis GC, Blumenthal DS, Sos TA: Fever and pulmonary thromboembolism. Am J Med 1979;67:232-235.
  21. Aburahma AF, Saiedy S: Deep vein thrombosis as probable cause of fever of unknown origin. WV Med J 1997;93:368-370.

    External Resources

  22. Kosch A, Junker R, Wermes C, Nowak-Göttl U: Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein (a). Thromb Res 2002;105:49-53.
  23. Matos MF, Lourenço DM, Orikaza CM, Bajerl JA, Noguti MA, Morelli VM: The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: a case-control study. Thromb Res 2011;128:216-220.
  24. Zetterstrom M, Sundgren-Andersson AK, Ostlund P, Bartfai T: Delineation of the proinflammatory cytokine cascade in fever induction. Ann NY Acad Sci 1998;856:48-52.
  25. Karavanaki K, Karanika E, Georga S, Bart-zeliotou A, Tsouvalas M, Konstantopoulos I, Fotinou A, Papassotiriou I, Karayianni C: Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J 2011;58:1045-1053.
  26. Appleberg M: The value of the postoperative temperature chart as an aid to the diagnosis of deep vein thrombosis. S Afr Med J 1976;50:2149-2150.

    External Resources

  27. Murawaki A, Nakayasu H, Doi M, Suzuki-Kinoshita K, Asai Y, Omura H, Nakashima K: Heparin-induced thrombocytopenia in essential thrombocytosis. J Stroke Cerebrovasc Dis 2012, E-pub ahead of print.
  28. Chalmers E, Ganesen V, Liesner R, Maroo S, Nokes T, Saunders D, Williams M, British Committee for Standards in Haematology: Guidelines on the investigation, management and prevention of venous thrombosis in children. Br J Haematol 2011;154:196-207.
  29. Montero RE, Baldominos UG, Lopez AJ, Santolaya PR: Effectiveness and safety of thromboprophylaxis with enoxaparin in medical inpatients. Thromb Res 2011;128:440-445.
  30. Monagle P, Michelson AD, Bovill E, Andrew M: Antithrombotic therapy in children. Chest 2001;119:S344-S370.

    External Resources

  31. Schobess R, During C, Bidlingmaier C, Heinecke A, Merkel N, Nowak-Gottl U: Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily en-oxaparin administration. Haematologica 2006;91:1701-1704.

    External Resources

  32. Guyatt GH, Aki EA, Crowther M, Gutterman DD, Schuunemann HJ, for the Amer-ican College of Chest Physicians Anti-thrombotic Therapy and Prevention of Thrombosis Panel: Executive summary: -Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians (ACCP) Evidence-Based Practice Guidelines. Chest 2012;141:7S-47S.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50